Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Mucosal Immunology
|
April 11, 2013
Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin
S U Jaeger, B O Schroeder, U Meyer-Hoffert, et al.
Leukemia & Lymphoma
|
March 26, 2002
Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia
D Heintel, I Schwarzinger, C Chizzali-Bonfadin, et al.
Allergy
|
March 23, 2017
BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils
D Smiljkovic, K Blatt, G Stefanzl, et al.
Leukemia
|
April 16, 2004
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)
G Mitterbauer-Hohendanner, C Mannhalter, K Winkler, et al.
Anticancer Research
|
January 30, 2008
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone
S Wöhrer, W Rabitsch, M Shehata, et al.
Leukemia & Lymphoma
|
November 8, 2001
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions
K Laczika, G Mitterbauer, M Mitterbauer, et al.
British Journal of Haematology
|
September 1, 1999
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction
G Mitterbauer, P Nemeth, S Wacha, et al.
American Journal of Clinical Pathology
|
March 8, 2000
High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study
M Mitterbauer, K Laczika, M Novak, et al.
Annals of Hematology
|
August 31, 2000
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)
E Reiter, H Greinix, W Rabitsch, et al.
Leukemia
|
February 24, 2001
Prognosis of patients with a second relapse of acute myeloid leukemia
B Stoiser, P Knöbl, C Fonatsch, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Mucosal Immunology
|
April 11, 2013
Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin
S U Jaeger, B O Schroeder, U Meyer-Hoffert, et al.
Leukemia & Lymphoma
|
March 26, 2002
Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia
D Heintel, I Schwarzinger, C Chizzali-Bonfadin, et al.
Allergy
|
March 23, 2017
BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils
D Smiljkovic, K Blatt, G Stefanzl, et al.
Leukemia
|
April 16, 2004
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)
G Mitterbauer-Hohendanner, C Mannhalter, K Winkler, et al.
Anticancer Research
|
January 30, 2008
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone
S Wöhrer, W Rabitsch, M Shehata, et al.
Leukemia & Lymphoma
|
November 8, 2001
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions
K Laczika, G Mitterbauer, M Mitterbauer, et al.
British Journal of Haematology
|
September 1, 1999
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction
G Mitterbauer, P Nemeth, S Wacha, et al.
American Journal of Clinical Pathology
|
March 8, 2000
High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study
M Mitterbauer, K Laczika, M Novak, et al.
Annals of Hematology
|
August 31, 2000
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26)
E Reiter, H Greinix, W Rabitsch, et al.
Leukemia
|
February 24, 2001
Prognosis of patients with a second relapse of acute myeloid leukemia
B Stoiser, P Knöbl, C Fonatsch, et al.
Page
of 14